Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

News Conference News ACC 2022

Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS

Michael O'Riordan

March 25, 2022

News Conference News ACC 2020

LAAO Registry: Safety of Watchman Looks Good in First Years of Rollout

Todd Neale

April 06, 2020

News Conference News ACC 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Michael O'Riordan

March 18, 2019

News Conference News ACC 2015

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Todd Neale

March 17, 2015

News Conference News ACC 2013

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Yael L. Maxwell

March 08, 2013

News Conference News ACC 2012

Transradial PCI Saves Money Compared with Transfemoral Access

L.A. McKeown

March 27, 2012

News Conference News ACC 2012

Benefits of Transradial PCI May be Limited to High Volume Centers

Jason Kahn

March 27, 2012

Presentation ACC 2012

Economic Impact of Transradial Percutaneous Coronary Intervention

Presenter: David Safley

March 24, 2012

Advertisement

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS

LAAO Registry: Safety of Watchman Looks Good in First Years of Rollout

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Transradial PCI Saves Money Compared with Transfemoral Access

Benefits of Transradial PCI May be Limited to High Volume Centers

Economic Impact of Transradial Percutaneous Coronary Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content